<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38672194</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>10</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Plasma Proteomics Elucidated a Protein Signature in COVID-19 Patients with Comorbidities and Early-Diagnosis Biomarkers.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">840</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines12040840</ELocationID><Abstract><AbstractText>Despite great scientific efforts, deep understanding of coronavirus-19 disease (COVID-19) immunopathology and clinical biomarkers remains a challenge. Pre-existing comorbidities increase the mortality rate and aggravate the exacerbated immune response against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, which can result in more severe symptoms as well as long-COVID and post-COVID complications. In this study, we applied proteomics analysis of plasma samples from 28 patients with SARS-CoV-2, with and without pre-existing comorbidities, as well as their corresponding controls to determine the systemic protein changes caused by the SARS-CoV-2 infection. As a result, the protein signature shared amongst COVID-19 patients with comorbidities was revealed to be characterized by alterations in the coagulation and complement pathways, acute-phase response proteins, tissue damage and remodeling, as well as cholesterol metabolism. These altered proteins may play a relevant role in COVID-19 pathophysiology. Moreover, several novel potential biomarkers for early diagnosis of the SARS-CoV-2 infection were detected, such as increased levels of keratin K22E, extracellular matrix protein-1 (ECM1), and acute-phase response protein &#x3b1;-2-antiplasmin (A2AP). Importantly, elevated A2AP may contribute to persistent clotting complications associated with the long-COVID syndrome in patients with comorbidities. This study provides new insights into COVID-19 pathogenesis and proposes novel potential biomarkers for early diagnosis that could be facilitated for clinical application by further validation studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Urbiola-Salvador</LastName><ForeName>V&#xed;ctor</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-8177-2744</Identifier><AffiliationInfo><Affiliation>Intercollegiate Faculty of Biotechnology of University of Gda&#x144;sk and Medical University of Gda&#x144;sk, University of Gda&#x144;sk, 80-307 Gda&#x144;sk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima de Souza</LastName><ForeName>Suiane</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1059-3041</Identifier><AffiliationInfo><Affiliation>Faculty of Biochemistry and Molecular Medicine, University of Oulu, 90220 Oulu, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macur</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3213-4447</Identifier><AffiliationInfo><Affiliation>Laboratory of Mass Spectrometry-Core Facility Laboratories, Intercollegiate Faculty of Biotechnology University of Gda&#x144;sk and Medical University of Gda&#x144;sk, University of Gda&#x144;sk, 80-309 Gda&#x144;sk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czaplewska</LastName><ForeName>Paulina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Mass Spectrometry-Core Facility Laboratories, Intercollegiate Faculty of Biotechnology University of Gda&#x144;sk and Medical University of Gda&#x144;sk, University of Gda&#x144;sk, 80-309 Gda&#x144;sk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-4658-7463</Identifier><AffiliationInfo><Affiliation>Faculty of Biochemistry and Molecular Medicine, University of Oulu, 90220 Oulu, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>decision numbers 325965, 335579</GrantID><Agency>Research Council of Finland</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">LC-MS/MS</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">acute-phase reaction</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">comorbidity</Keyword><Keyword MajorTopicYN="N">complement</Keyword><Keyword MajorTopicYN="N">diagnosis</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">plasma proteomics</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38672194</ArticleId><ArticleId IdType="pmc">PMC11048573</ArticleId><ArticleId IdType="doi">10.3390/biomedicines12040840</ArticleId><ArticleId IdType="pii">biomedicines12040840</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Parasher A. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgrad. Med. J. 2021;97:312&#x2013;320. doi: 10.1136/postgradmedj-2020-138577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-138577</ArticleId><ArticleId IdType="pmc">PMC10017004</ArticleId><ArticleId IdType="pubmed">32978337</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375:1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejaz H., Alsrhani A., Zafar A., Javed H., Junaid K., Abdalla A.E., Abosalif K.O.A., Ahmed Z., Younas S. COVID-19 and comorbidities: Deleterious impact on infected patients. J. Infect. Public Health. 2020;13:1833&#x2013;1839. doi: 10.1016/j.jiph.2020.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.07.014</ArticleId><ArticleId IdType="pmc">PMC7402107</ArticleId><ArticleId IdType="pubmed">32788073</ArticleId></ArticleIdList></Reference><Reference><Citation>Belchior-Bezerra M., Lima R.S., Medeiros N.I., Gomes J.A.S. COVID-19, obesity, and immune response 2&#x2009;years after the pandemic: A timeline of scientific advances. Obes. Rev. 2022;23:e13496. doi: 10.1111/obr.13496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.13496</ArticleId><ArticleId IdType="pmc">PMC9349458</ArticleId><ArticleId IdType="pubmed">35837843</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S., Li X., Xin Z., Sun L., Shi J. Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods. Front. Immunol. 2022;13:923387. doi: 10.3389/fimmu.2022.923387.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.923387</ArticleId><ArticleId IdType="pmc">PMC9530739</ArticleId><ArticleId IdType="pubmed">36203586</ArticleId></ArticleIdList></Reference><Reference><Citation>Wi&#x15b;niewski J.R. Filter Aided Sample Preparation&#x2014;A tutorial. Anal. Chim. Acta. 2019;1090:23&#x2013;30. doi: 10.1016/j.aca.2019.08.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2019.08.032</ArticleId><ArticleId IdType="pubmed">31655642</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappsilber J., Mann M., Ishihama Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2007;2:1896&#x2013;1906. doi: 10.1038/nprot.2007.261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2007.261</ArticleId><ArticleId IdType="pubmed">17703201</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team  . A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; Vienna, Austria: 2022.  [(accessed on 12 January 2024)].  Available online:  https://www.R-project.org/</Citation></Reference><Reference><Citation>RStudio Team  . RStudio: Integrated Development Environment for R. RStudio, PBC; Boston, MA, USA: 2022.  [(accessed on 12 January 2024)].  Available online:  http://www.rstudio.com/</Citation></Reference><Reference><Citation>Sticker A., Goeminne L., Martens L., Clement L. Robust Summarization and Inference in Proteome-wide Label-free Quantification. Mol. Cell. Proteom. 2020;19:1209&#x2013;1219. doi: 10.1074/mcp.RA119.001624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.RA119.001624</ArticleId><ArticleId IdType="pmc">PMC7338080</ArticleId><ArticleId IdType="pubmed">32321741</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y., Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B. 1995;57:289&#x2013;300. doi: 10.1111/j.2517-6161.1995.tb02031.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1995.tb02031.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulgen E., Ozisik O., Sezerman O.U. PathfindR: An R package for comprehensive identification of enriched pathways in omics data through active subnetworks. Front. Genet. 2019;10:858. doi: 10.3389/fgene.2019.00858.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00858</ArticleId><ArticleId IdType="pmc">PMC6773876</ArticleId><ArticleId IdType="pubmed">31608109</ArticleId></ArticleIdList></Reference><Reference><Citation>Overmyer K.A., Shishkova E., Miller I.J., Balnis J., Bernstein M.N., Peters-Clarke T.M., Meyer J.G., Quan Q., Muehlbauer L.K., Trujillo E.A., et al. Large-Scale Multi-omic Analysis of COVID-19 Severity. Cell Syst. 2021;12:23&#x2013;40.e7. doi: 10.1016/j.cels.2020.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2020.10.003</ArticleId><ArticleId IdType="pmc">PMC7543711</ArticleId><ArticleId IdType="pubmed">33096026</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J.-J., Wang C.-W., Liu Y., Zhang Y.-Y., Yang N.-B., Yu Y.-C., Jiang Q., Song Q.-F., Qian G.-Q. Role of the extracellular matrix in COVID-19. World J. Clin. Cases. 2023;11:73&#x2013;83. doi: 10.12998/wjcc.v11.i1.73.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v11.i1.73</ArticleId><ArticleId IdType="pmc">PMC9846981</ArticleId><ArticleId IdType="pubmed">36687194</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung M.L., Teng J.L.L., Jia L., Zhang C., Huang C., Cai J.-P., Zhou R., Chan K.-H., Zhao H., Zhu L., et al. Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system. Cell. 2021;184:2212&#x2013;2228.e12. doi: 10.1016/j.cell.2021.02.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.053</ArticleId><ArticleId IdType="pmc">PMC7923941</ArticleId><ArticleId IdType="pubmed">33713620</ArticleId></ArticleIdList></Reference><Reference><Citation>Razanakolona M., Adam F., Bianchini E., Saller F., de Carvalho A., Diehl J.-L., Denis C.V., Meziani F., Borgel D., Helms J., et al. Anti-inflammatory Activity of the Protein Z-Dependent Protease Inhibitor. TH Open. 2021;05:e220&#x2013;e229. doi: 10.1055/s-0041-1730037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1730037</ArticleId><ArticleId IdType="pmc">PMC8233056</ArticleId><ArticleId IdType="pubmed">34189397</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill L.A., Bodnar T.S., Weinberg J., Hammond G.L. Corticosteroid-Binding Globulin is a biomarker of inflammation onset and severity in female rats. J. Endocrinol. 2016;230:215&#x2013;225. doi: 10.1530/JOE-16-0047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/JOE-16-0047</ArticleId><ArticleId IdType="pmc">PMC5338597</ArticleId><ArticleId IdType="pubmed">27418032</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilser J.R., Han Y., Biswas S., Gukasyan J., Cai Z., Zhu R., Tang W.H.W., Deb A., Lusis A.J., Hartiala J.A., et al. Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection. J. Lipid Res. 2021;62:100061. doi: 10.1016/j.jlr.2021.100061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jlr.2021.100061</ArticleId><ArticleId IdType="pmc">PMC7923911</ArticleId><ArticleId IdType="pubmed">33667465</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Ma Z., Raman A., Beckerman P., Dhillon P., Mukhi D., Palmer M., Chen H.C., Cohen C.R., Dunn T., et al. APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis. Immunity. 2021;54:2632&#x2013;2649.e6. doi: 10.1016/j.immuni.2021.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.10.004</ArticleId><ArticleId IdType="pmc">PMC9338439</ArticleId><ArticleId IdType="pubmed">34715018</ArticleId></ArticleIdList></Reference><Reference><Citation>Oczypok E.A., Perkins T.N., Oury T.D. All the &#x201c;RAGE&#x201d; in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses. Paediatr. Respir. Rev. 2017;23:40&#x2013;49. doi: 10.1016/j.prrv.2017.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2017.03.012</ArticleId><ArticleId IdType="pmc">PMC5509466</ArticleId><ArticleId IdType="pubmed">28416135</ArticleId></ArticleIdList></Reference><Reference><Citation>Bierhaus A., Schiekofer S., Schwaninger M., Andrassy M., Humpert P.M., Chen J., Hong M., Luther T., Henle T., Kl&#xf6;ting I., et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-&#x3ba;B. Diabetes. 2001;50:2792&#x2013;2808. doi: 10.2337/diabetes.50.12.2792.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.50.12.2792</ArticleId><ArticleId IdType="pubmed">11723063</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavezzi A., Troiani E., Corrao S. COVID-19: Hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin. Pract. 2020;10:1271. doi: 10.4081/cp.2020.1271.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/cp.2020.1271</ArticleId><ArticleId IdType="pmc">PMC7267810</ArticleId><ArticleId IdType="pubmed">32509258</ArticleId></ArticleIdList></Reference><Reference><Citation>Camps J., Iftimie S., Garc&#xed;a-Heredia A., Castro A., Joven J. Paraoxonases and infectious diseases. Clin. Biochem. 2017;50:804&#x2013;811. doi: 10.1016/j.clinbiochem.2017.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2017.04.016</ArticleId><ArticleId IdType="pubmed">28433610</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaller J., Gerber S.S. The plasmin&#x2013;antiplasmin system: Structural and functional aspects. Cell. Mol. Life Sci. 2011;68:785&#x2013;801. doi: 10.1007/s00018-010-0566-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-010-0566-5</ArticleId><ArticleId IdType="pmc">PMC11115092</ArticleId><ArticleId IdType="pubmed">21136135</ArticleId></ArticleIdList></Reference><Reference><Citation>Java A., Apicelli A.J., Kathryn Liszewski M., Coler-Reilly A., Atkinson J.P., Kim A.H., Kulkarni H.S. The complement system in COVID-19: Friend and foe? JCI Insight. 2020;5:e14071. doi: 10.1172/jci.insight.140711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140711</ArticleId><ArticleId IdType="pmc">PMC7455060</ArticleId><ArticleId IdType="pubmed">32554923</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry B.M., Szergyuk I., de Oliveira M.H.S., Lippi G., Benoit J.L., Vikse J., Benoit S.W. Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state. J. Med. Virol. 2021;93:5515&#x2013;5522. doi: 10.1002/jmv.27077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27077</ArticleId><ArticleId IdType="pmc">PMC8242600</ArticleId><ArticleId IdType="pubmed">33974276</ArticleId></ArticleIdList></Reference><Reference><Citation>Marfia G., Navone S., Guarnaccia L., Campanella R., Mondoni M., Locatelli M., Barassi A., Fontana L., Palumbo F., Garzia E., et al. Decreased serum level of sphingosine-1-phosphate: A novel predictor of clinical severity in COVID-19. EMBO Mol. Med. 2021;13:e13424. doi: 10.15252/emmm.202013424.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202013424</ArticleId><ArticleId IdType="pmc">PMC7744841</ArticleId><ArticleId IdType="pubmed">33190411</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurt N., Ozgeris F.B., Kocak O.F., Yuce N., Bayraktutan Z., Parlak E., Coban T.A., Bakan E. Evaluation of fetuin-A, CRP, and CRP/fetuin-A values in COVID-19 patients. Int. J. Med. Biochem. 2022;5:125&#x2013;131. doi: 10.14744/ijmb.2022.83097.</Citation><ArticleIdList><ArticleId IdType="doi">10.14744/ijmb.2022.83097</ArticleId></ArticleIdList></Reference><Reference><Citation>Corneo E., Garbelotto R., Prestes G., Girardi C.S., Santos L., Moreira J.C.F., Gelain D.P., Westphal G.A., Kupek E., Walz R., et al. Coagulation biomarkers and coronavirus disease 2019 phenotyping: A prospective cohort study. Thromb. J. 2023;21:80. doi: 10.1186/s12959-023-00524-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12959-023-00524-0</ArticleId><ArticleId IdType="pmc">PMC10375602</ArticleId><ArticleId IdType="pubmed">37507773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.-S., Han D., Kim S.Y., Hong K.H., Jang M.-J., Kim M.J., Kim Y.-G., Park J.H., Cho S.I., Park W.B., et al. Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID-19 progression. Proteomics. 2021;21:e2000278. doi: 10.1002/pmic.202000278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.202000278</ArticleId><ArticleId IdType="pmc">PMC8206655</ArticleId><ArticleId IdType="pubmed">33945677</ArticleId></ArticleIdList></Reference><Reference><Citation>Feingold K.R. The bidirectional interaction of COVID-19 infections and lipoproteins. Best Pract. Res. Clin. Endocrinol. Metab. 2023;37:101751. doi: 10.1016/j.beem.2023.101751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem.2023.101751</ArticleId><ArticleId IdType="pmc">PMC9951034</ArticleId><ArticleId IdType="pubmed">36894344</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke-Cohan J.S., Gu J., Mclaughlin D.F., Xu Y., Freeman G.J., Schlossman S.F. Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions. Proc. Natl. Acad. Sci. USA. 1998;95:11336&#x2013;11341. doi: 10.1073/pnas.95.19.11336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.19.11336</ArticleId><ArticleId IdType="pmc">PMC21643</ArticleId><ArticleId IdType="pubmed">9736737</ArticleId></ArticleIdList></Reference><Reference><Citation>He L., Gu W., Wang M., Chang X., Sun X., Zhang Y., Lin X., Yan C., Fan W., Su P., et al. Extracellular matrix protein 1 promotes follicular helper T cell differentiation and antibody production. Proc. Natl. Acad. Sci. USA. 2018;115:8621&#x2013;8626. doi: 10.1073/pnas.1801196115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1801196115</ArticleId><ArticleId IdType="pmc">PMC6112729</ArticleId><ArticleId IdType="pubmed">30087185</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostami M., Mansouritorghabeh H., Parsa-Kondelaji M. High levels of Von Willebrand factor markers in COVID-19: A systematic review and meta-analysis. Clin. Exp. Med. 2022;22:347&#x2013;357. doi: 10.1007/s10238-021-00769-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-021-00769-x</ArticleId><ArticleId IdType="pmc">PMC8571968</ArticleId><ArticleId IdType="pubmed">34741678</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu T., Ning W., Wu D., Xu J., Han Q., Huang M., Zou X., Yang Q., Yuan Y., Bie Y., et al. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19. Immunity. 2020;53:1108&#x2013;1122.e5. doi: 10.1016/j.immuni.2020.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.10.008</ArticleId><ArticleId IdType="pmc">PMC7574896</ArticleId><ArticleId IdType="pubmed">33128875</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Alessandro A., Thomas T., Dzieciatkowska M., Hill R.C., Francis R.O., Hudson K.E., Zimring J.C., Hod E.A., Spitalnik S.L., Hansen K.C. Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level. J. Proteome Res. 2020;19:4417&#x2013;4427. doi: 10.1021/acs.jproteome.0c00365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00365</ArticleId><ArticleId IdType="pmc">PMC7640953</ArticleId><ArticleId IdType="pubmed">32786691</ArticleId></ArticleIdList></Reference><Reference><Citation>Geyer P.E., Arend F.M., Doll S., Louiset M.-L., Virreira Winter S., M&#xfc;ller-Reif J.B., Torun F.M., Weigand M., Eichhorn P., Bruegel M., et al. High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion. EMBO Mol. Med. 2021;13:e14167. doi: 10.15252/emmm.202114167.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202114167</ArticleId><ArticleId IdType="pmc">PMC8687121</ArticleId><ArticleId IdType="pubmed">34232570</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbin M.R., Mehta A., Schneider A.M., Kays K.R., Guess J.R., Gentili M., Fenyves B.G., Charland N.C., Gonye A.L.K., Gushterova I., et al. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep. Med. 2021;2:100287. doi: 10.1016/j.xcrm.2021.100287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100287</ArticleId><ArticleId IdType="pmc">PMC8091031</ArticleId><ArticleId IdType="pubmed">33969320</ArticleId></ArticleIdList></Reference><Reference><Citation>Keur N., Saridaki M., Rica&#xf1;o-Ponce I., Netea M.G., Giamarellos-Bourboulis E.J., Kumar V. Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes. Respir. Med. 2023;217:107331. doi: 10.1016/j.rmed.2023.107331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2023.107331</ArticleId><ArticleId IdType="pmc">PMC10290733</ArticleId><ArticleId IdType="pubmed">37364721</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahnavard A., Mann B., Giri A., Chatterjee R., Crandall K.A. Metabolite, protein, and tissue dysfunction associated with COVID-19 disease severity. Sci. Rep. 2022;12:12204. doi: 10.1038/s41598-022-16396-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-16396-9</ArticleId><ArticleId IdType="pmc">PMC9288092</ArticleId><ArticleId IdType="pubmed">35842456</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Wang S., Wong C.C.L. Proteomics research of SARS-CoV-2 and COVID-19 disease. Med. Rev. 2022;2:427&#x2013;445. doi: 10.1515/mr-2022-0016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/mr-2022-0016</ArticleId><ArticleId IdType="pmc">PMC10388787</ArticleId><ArticleId IdType="pubmed">37724330</ArticleId></ArticleIdList></Reference><Reference><Citation>Alosaimi B., Mubarak A., Hamed M.E., Almutairi A.Z., Alrashed A.A., AlJuryyan A., Enani M., Alenzi F.Q., Alturaiki W. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality. Front. Immunol. 2021;12:668725. doi: 10.3389/fimmu.2021.668725.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.668725</ArticleId><ArticleId IdType="pmc">PMC8281279</ArticleId><ArticleId IdType="pubmed">34276659</ArticleId></ArticleIdList></Reference><Reference><Citation>Risitano A.M., Mastellos D.C., Huber-Lang M., Yancopoulou D., Garlanda C., Ciceri F., Lambris J.D. Complement as a target in COVID-19? Nat. Rev. Immunol. 2020;20:343&#x2013;344. doi: 10.1038/s41577-020-0320-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0320-7</ArticleId><ArticleId IdType="pmc">PMC7187144</ArticleId><ArticleId IdType="pubmed">32327719</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierko E., Zabrocka E., Ostrowska-Cichocka K., Tokajuk P., Zimnoch L., Wojtukiewicz M.Z. Co-localization of Coagulation Factor X and its Inhibitory System, PZ/ZPI, in Human Endometrial Cancer Tissue. In Vivo. 2019;33:771&#x2013;776. doi: 10.21873/invivo.11538.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.11538</ArticleId><ArticleId IdType="pmc">PMC6559914</ArticleId><ArticleId IdType="pubmed">31028196</ArticleId></ArticleIdList></Reference><Reference><Citation>Toomer K.H., Gerber G.F., Zhang Y., Daou L., Tushek M., Hooper J.E., Francischetti I.M.B. SARS-CoV-2 infection results in upregulation of Plasminogen Activator Inhibitor-1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity. eJHaem. 2023;4:324&#x2013;338. doi: 10.1002/jha2.654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jha2.654</ArticleId><ArticleId IdType="pmc">PMC10188457</ArticleId><ArticleId IdType="pubmed">37206290</ArticleId></ArticleIdList></Reference><Reference><Citation>van Lier D., Kox M., Pickkers P. Commentary: Plasma angiotensin II is increased in critical coronavirus disease 2019. Front. Cardiovasc. Med. 2022;9:1012452. doi: 10.3389/fcvm.2022.1012452.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.1012452</ArticleId><ArticleId IdType="pmc">PMC9618702</ArticleId><ArticleId IdType="pubmed">36324738</ArticleId></ArticleIdList></Reference><Reference><Citation>van Lier D., Kox M., Santos K., van der Hoeven H., Pillay J., Pickkers P. Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients. ERJ Open Res. 2021;7:00848-2020. doi: 10.1183/23120541.00848-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00848-2020</ArticleId><ArticleId IdType="pmc">PMC7848790</ArticleId><ArticleId IdType="pubmed">33738305</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbiola-Salvador V., Lima de Souza S., Gre&#x161;ner P., Qureshi T., Chen Z. Plasma Proteomics Unveil Novel Immune Signatures and Biomarkers upon SARS-CoV-2 Infection. Int. J. Mol. Sci. 2023;24:6276. doi: 10.3390/ijms24076276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076276</ArticleId><ArticleId IdType="pmc">PMC10093853</ArticleId><ArticleId IdType="pubmed">37047248</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoch N.E., Guzik T.J., Chen W., Deans T., Maalouf S.A., Gratze P., Weyand C., Harrison D.G. Regulation of T-cell function by endogenously produced angiotensin II. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009;296:R208&#x2013;R216. doi: 10.1152/ajpregu.90521.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.90521.2008</ArticleId><ArticleId IdType="pmc">PMC2643984</ArticleId><ArticleId IdType="pubmed">19073907</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabald&#xf3; X., Juanpere M., Casta&#xf1;&#xe9; H., Rodr&#xed;guez-Tom&#xe0;s E., L&#xf3;pez-Azcona A.F., Baiges-Gaya G., Castro L., Valverde-D&#xed;az E., Mu&#xf1;oz-Bl&#xe1;zquez A., Gim&#xe9;nez-Cuenca L., et al. Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19. Biomolecules. 2022;12:879. doi: 10.3390/biom12070879.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12070879</ArticleId><ArticleId IdType="pmc">PMC9312761</ArticleId><ArticleId IdType="pubmed">35883435</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammad Y., Kani Y.A., Iliya S., Muhammad J.B., Binji A., El-Fulaty Ahmad A., Kabir M.B., Umar Bindawa K., Ahmed A. Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: A cross-sectional comparative study in Jigawa, Northwestern Nigeria. SAGE Open Med. 2021;9:2050312121991246. doi: 10.1177/2050312121991246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050312121991246</ArticleId><ArticleId IdType="pmc">PMC7871282</ArticleId><ArticleId IdType="pubmed">33614035</ArticleId></ArticleIdList></Reference><Reference><Citation>Dworza&#x144;ski J., Strycharz-Dudziak M., Kliszczewska E., Kie&#x142;czykowska M., Dworza&#x144;ska A., Drop B., Polz-Dacewicz M. Glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity in patients with diabetes mellitus type 2 infected with Epstein-Barr virus. PLoS ONE. 2020;15:e0230374. doi: 10.1371/journal.pone.0230374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0230374</ArticleId><ArticleId IdType="pmc">PMC7094858</ArticleId><ArticleId IdType="pubmed">32210468</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C., Kraft K. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C. Front. Pharmacol. 2022;13:899198. doi: 10.3389/fphar.2022.899198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q., Bai S.-Y., Li L.-F., Li S., Zhang Y., Munir M., Qiu H.-J. Human Hemoglobin Subunit Beta Functions as a Pleiotropic Regulator of RIG-I/MDA5-Mediated Antiviral Innate Immune Responses. J. Virol. 2019;93:e00718-19. doi: 10.1128/JVI.00718-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00718-19</ArticleId><ArticleId IdType="pmc">PMC6675906</ArticleId><ArticleId IdType="pubmed">31167908</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Lin F., Liu F., Li Q., Li Y., Zhu Z., Guo H., Liu L., Liu X., Liu W., et al. Proteomic profiling reveals a distinctive molecular signature for critically ill COVID-19 patients compared with asthma and chronic obstructive pulmonary disease. Int. J. Infect. Dis. 2022;116:258&#x2013;267. doi: 10.1016/j.ijid.2022.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.01.008</ArticleId><ArticleId IdType="pmc">PMC8743279</ArticleId><ArticleId IdType="pubmed">35017110</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>